Newbridge Financial Services Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18K | Buy |
|
|||||
|
2025
Q1 | $19.1K | Hold |
|
|||||
|
2024
Q4 | $36.5K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $47.4K | Hold |
|
|||||
|
2024
Q1 | $38.8K | Hold |
|
|||||
|
2023
Q4 | $28.9K | Sell |
|
|||||
|
2023
Q3 | $41.6K | Sell |
|
|||||
|
2023
Q2 | $73.6K | Hold |
|
|||||
|
2023
Q1 | $88.6K | Hold |
|
|||||
|
2022
Q4 | $83.3K | Hold |
|
|||||
|
2022
Q3 | $71K | Sell |
|
|||||
|
2022
Q2 | $61K | Sell |
|
|||||
|
2022
Q1 | $93K | Buy |
|
|||||
|
2021
Q4 | $104K | Sell |
|
|||||
|
2021
Q3 | $121K | Buy |
|
|||||
|
2021
Q2 | $98K | Buy |
|
|||||
|
2021
Q1 | $88K | Buy |
|
|||||
|
2020
Q4 | $102K | Hold |
|
|||||
|
2020
Q3 | $84K | Buy |
|